期刊文献+

72例老年药物性肝损害的临床特征及病理分析 被引量:6

Clinical Features and Pathological Analysis of 72 Elderly Patients with Drug-induced Liver Injury
原文传递
导出
摘要 目的:分析老年药物性肝损害(DILI)的常见引发药物种类、临床特征、病理特点和预后,以提高对该病的诊治水平。方法:回顾性分析2009年2月~2012年2月72例老年DILI患者资料,对其用药史、临床表现、肝功能、凝血功能、病原学标志、病理表现以及治疗转归进行综合分析。结果:引起老年DILI前5位的药物分别是中药43例(59.8%)、降血糖药8例(11.1%)、心血管药7例(9.7%)、抗菌药6例(8.3%)、抗结核药5例(6.9%)。DILI临床分类:药物性肝衰竭15例(20.8%)、急性药物性肝损害36例(50%)、慢性药物性肝损害17例(23.6%)、药物性肝硬化4例(5.6%)。主要病理改变为肝细胞坏死、肝细胞水样变性、汇管区扩大、肝细胞脂肪变性、纤维组织增生、嗜酸性粒细胞浸润、汇管区或肝窦内混合炎细胞浸润等。72例患者中治愈26例(36.1%),好转31例(43.1%),无效11例(15.3%),死亡4例(5.6%)。结论:老年DILI患者有其不同的引发药物谱,其临床表现和实验室检查缺乏特异性,但死亡率较高。因此,对于老年患者用药应严格把握适应证,密切监测肝功能,早期治疗。 Objective:To investigate the types of causative agents,clinical pathological features,and related prognosis factors of elderly patient with drug-induced liver disease(DILI) in order to improve the diagnosis and treatment of DILI.Methods:72 elderly patients with DILI admitted to our hospital from February 2009 to February 2012 were retrospectively reviewed according to their drug history,clinical features,lab tests,pathological characteristics,and related prognosis factors.Results:The primary etiological drugs of elderly patient with DILI were herbal medicine(59.8%).hypoglycemic agents(11.1%),cardiovascular drugs(9.7%),antibiotics(8.3%)and anti-tuberculosis drugs(6.9%).Their DILIs were 15 cases of drug-induced liver failure(20.8%%),36 cases of acute DILI(50%) and 17 cases of chronic DILI (23.6%),4 cases of drug-induced live cirrhosis(5.6%),respectively.The predominant pathology of DILI was hepatocyte necrosis,hepatocyte hydropic degeneration,hepatocyte fatty degeneration,hepatic portal area enlargement,fibroplasia,eosinophils infiltration,mixed inflammatory cell infiltration in hepatic portal area or hepatic sinusoid,cholestasis,hepatocyte apoptosis and Kupffer cell proliferation.Conclusion:The DILI in elderly patients had the different types of causative agents but no specific clinical manifestation.Elderly patients with DILI had the higher mortality(5.6%vs 2.6%).Therefore, their hepatic function should be dynamically monitored in the application of related drugs to diagnose and treat them early.
机构地区 解放军第
出处 《药物流行病学杂志》 CAS 2013年第5期242-245,共4页 Chinese Journal of Pharmacoepidemiology
关键词 老年患者 药物性肝损害 临床特征 预后 Elderly patient Drug-induced liver injury Clinical features Prognosis
  • 相关文献

参考文献15

  • 1Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis [ J ]. Hepatology, 1997,26 ( 3 ) : 664 -669.
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 3Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting[ J]. J Hepatol, 1990, 11:272-276.
  • 4Boelsterli UA, Lim PL. Mitochondrial abnormalities a link to idiosyncratic drug hepatotoxicity? [J]. Toxicol Appl Pharmacol,2007,220( 1 ) : 92-107.
  • 5Russmann S, Kullak-Ublick GA, Grattagliano I. Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity [J]. Curt Med Chem,2009 , 16(23) :3041-3053.
  • 6Agundez JA, Ladero JM. Glutathione S-transferase GSTY1 and GSTM1 allozymes: beyond null alleles[ J]. Pharmacogenomics, 2008, 9 (3) : 359-363.
  • 7Willis C, Maddrey W. Drug-induced hepatotoxicity [ J ]. J Clin Gastroenterol, 2005,39 (4Suppl2) :S83.
  • 8Au JS, Navarro VJ, Rossi S. Review article: drug-induced liver injury - its pathophysiology and evolving diagnostic tools [J]. Aliment Pharmacol Ther, 2011,34( 1 ) :11-20.
  • 9Aithal GP, Watkins PB, Andrade R J, et al. Case definition and phenotype standardization in drug-induced liver injury [J]. Clin Pharmaeol Ther,2011,89( 6) :806-815.
  • 10Bjornsson E, Davidsdottir L. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice [ J ]. J Hepatol, 2009,50 : 511-517.

二级参考文献36

共引文献911

同被引文献85

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部